Initiated in Spring 2003, the REACH Leukaemia Appeal was launched with the purpose of raising approximately £1.2 million for the advancement of pioneering research work into infant and childhood leukaemia at the Molecular Haematology and Cancer Biology Unit (MHCB) at the Institute of Child Health and Great Ormond Street Hospital in London. The unit leads the way in the UK in the fields of understanding leukaemia and evolving new, less toxic treatments to treat the disease.

By providing funds for this research platform, the Appeal aims to be an important building block in the discovery and implementation of improved treatments and a long-term cure for childhood leukaemia.